The SARS-CoV-2 virus emerged in December 2019 and has caused a worldwide pandemic
due to the lack of any pre-existing immunity. Accurate serology testing is urgently needed to …

SARS-CoV-2 infection of children leads to a mild illness and the immunological differences
with adults are unclear. Here, we report SARS-CoV-2 specific T cell responses in infected …

The antibody response magnitude and kinetics may impact clinical severity, serological
diagnosis and long-term protection of COVID-19, which may play a role in why children …

The SARS-CoV-2 Omicron variant has demonstrated enhanced transmissibility and escape
of vaccine-derived immunity. Although first-generation vaccines remain effective against …

In March 2020, mild signs and symptoms of coronavirus disease developed in a healthy 33-year-old
man in Hong Kong. His first infection did not produce virus neutralizing antibodies. …

We present an interim analysis of a registered clinical study (NCT04800133) to establish
immunobridging with various antibody and cellular immunity markers and to compare the …

Background The SARS-CoV-2 virus emerged in December 2019 and caused a pandemic
associated with a spectrum of COVID-19 disease ranging from asymptomatic to lethal infection…

SARS-CoV-2 virions are composed of structural proteins, but during virus infection, an
additional 30 proteins could be expressed according to putative open reading frames (ORFs) of …

Background: Children are less clinically affected by SARS-CoV-2 infection than adults with
the majority of cases being mild or asymptomatic and the differences in infection outcomes …

Nucleocapsid (N) encoded by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
plays key roles in the replication cycle and is a critical serological marker. Here, we …